IPVC 2020: 33rd International Papillomavirus Conference

IPVC 2020: 33rd International Papillomavirus Conference is organized by International Papillomavirus Society (IPVS), Kenes Group and will be held from Jul 20 - 24, 2020 at International Barcelona Convention Center, Barcelona, Catalonia, Spain.

Target Audience:
The 33rd International Papillomavirus Conference is the global meeting place for researchers, clinicians and other health professionals to share knowledge and ideas on papillomaviruses and their associated diseases. Because of the diverse, clinically focused educational offering, participants are able to tailor the curriculum to meet the needs of international clinicians of all levels of experience.

Accreditation:
The 33rd International Papillomavirus Conference is designated for a maximum of, or up to, 34 European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Description:
The conference theme is “Science and education for action against HPV” and through workshops, invited lectures, and oral and poster sessions presenting the latest research results, the conference will cover papillomavirus (PV)-related topics from basic science to global health impact. We will be paying special attention to HPV prevention and control in populations that are most vulnerable to HPV disease worldwide, including those in Low and Middle Income Countries.

Educational Objectives:
After attending this event, participants should be able to:

• Address individual needs in compliance with their Continuous Professional Development (CPD) plan.
• Discuss epidemiology and molecular biology of papillomavirus. Address the most recent advances across the spectrum of PV research.
• Enhance new relationships with colleagues with common interests throughout the world.
• Discuss the latest developments in therapeutic and prophylactic vaccines.
• Identify educational resources and networks for exchange of knowledge and learning about HPV.
• Review the prevention of HPV associated cancers particularly cervical cancer and other PV-associated diseases.
• Examine animal models for the study of papillomavirus disease.